GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Athena Technology Acquisition Corp II (AMEX:ATEK) » Definitions » Risk Assessment

Athena Technology Acquisition II (Athena Technology Acquisition II) Risk Assessment


View and export this data going back to 2022. Start your Free Trial

What is Athena Technology Acquisition II Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Athena Technology Acquisition II is: No Data: Cannot be evaluated.

Competitive Comparison of Athena Technology Acquisition II's Risk Assessment

For the Shell Companies subindustry, Athena Technology Acquisition II's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Athena Technology Acquisition II's Risk Assessment Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Athena Technology Acquisition II's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Athena Technology Acquisition II's Risk Assessment falls into.


Athena Technology Acquisition II  (AMEX:ATEK) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Athena Technology Acquisition II Risk Assessment Related Terms

Thank you for viewing the detailed overview of Athena Technology Acquisition II's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Athena Technology Acquisition II (Athena Technology Acquisition II) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Athena Technology Acquisition Corp II (AMEX:ATEK) » Definitions » Risk Assessment
Comparable Companies
VMCA ACAH DHCA ZLS BMAC LGVC GPAC FIAC IRRX CSTA PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA
Traded in Other Exchanges
N/A
Address
442 5th Avenue, New York, NY, USA, 10018
Website
https://www.athenaspac.com
Athena Technology Acquisition Corp II is a blank check company.
Executives
Trier Bryant director 2220 WESTCREEK LN 1404, HOUSTON TX 77027
Judith Rodin director C/O UNIVERSITY OF PENNSYLVANIA, 100 COLLEGE HALL, PHILADELPHIA PA 19104-6380
Sharon Brown-hruska director C/O MARKETAXESS HOLDINGS INC., 299 PARK AVENUE, NEW YORK NY 10171
Randi Zuckerberg director 394 PACIFIC AVE., SUITE 2, SAN FRANCISCO CA 94111
Kirthiga Reddy officer: President C/O PEAR THERAPEUTICS, INC., 200 STATE STREET, 13TH FLOOR, BOSTON MA 02109
Isabelle D. Freidheim director, 10 percent owner, officer: Chief Executive Officer 125 TOWNPARK DRIVE, SUITE 300, KENNESAW GA 30144
Athena Technology Sponsor Ii, Llc 10 percent owner 442 5TH AVENUE, NEW YORK NY 10018
Anna Apostolova officer: Chief Financial Officer C/O ATHENA TECHNOLOGY ACQUISITION CORP., 442 5TH AVENUE, NEW YORK NY 10018